MCAC Role Is To Determine Relative Technology Benefit - Draft Proposal
This article was originally published in The Gray Sheet
Executive Summary
Medicare Coverage Advisory Committee panels, in performing assessments for the Health Care Financing Administration, should determine the degree to which a new medical technology offers a clinical benefit over an established treatment, according to an unrevised draft proposal by an MCAC executive subcommittee.